Immunotherapy for Third Line Metastatic Colorectal Cancer

NCT04444622 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mirror Biologics, Inc.